menu
    • menu

    Looking for Sorbitan Monolaurate pharmaceutical excipients? Find information on Sorbitan Monolaurate's applications, manufacturers, suppliers, etc. on PharmaCompass.

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass

    Chemistry

    Click the arrow to open the dropdown
    read-moreClick the button for full data set
    read-moreClick the button for full data set

    FINISHED DOSAGE FORMULATIONS

    Upload your portfolio for free, ask us

    FDF DOSSIERS SUPPLIERS

    read-more
    read-more

    01

    ABBVIE
    U.S.A
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR

    Drug : VIEKIRA PAK (COPACKAGED)

    Dosage Form : TABLET; ORAL

    Application Number : 206619

    Country : US

    Patented : Yes

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    ABBVIE
    U.S.A
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RITONAVIR

    Drug : NORVIR

    Dosage Form : TABLET; ORAL

    Application Number : 22417

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    ABBVIE
    U.S.A
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    LOPINAVIR; RITONAVIR

    Drug : KALETRA

    Dosage Form : TABLET; ORAL

    Application Number : 21906

    Country : US

    Patented : No

    Abbvie Company Banner

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    ACERUS PHARMS

    DESMOPRESSIN ACETATE

    arrow
    ASC 2024
    Not Confirmed
    ACERUS PHARMS
    Canada
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    DESMOPRESSIN ACETATE

    Drug : NOCTIVA

    Dosage Form : SPRAY, METERED; NASAL

    Application Number : 201656

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    ALKERMES INC

    ARIPIPRAZOLE LAUROXIL

    arrow
    ASC 2024
    Not Confirmed
    ALKERMES INC
    Ireland
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ARIPIPRAZOLE LAUROXIL

    Drug : ARISTADA

    Dosage Form : SUSPENSION, EXTENDED RELEASE; INTRAMUSCULAR

    Application Number : 207533

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    AUROBINDO PHARMA LTD

    RITONAVIR

    arrow
    ASC 2024
    Not Confirmed
    AUROBINDO PHARMA LTD
    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RITONAVIR

    Drug : RITONAVIR

    Dosage Form : TABLET; ORAL

    Application Number : 206614

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    CIPLA

    RITONAVIR

    arrow
    ASC 2024
    Not Confirmed
    CIPLA
    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RITONAVIR

    Drug : RITONAVIR

    Dosage Form : TABLET; ORAL

    Application Number : 202573

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    GLENMARK PHARMS LTD

    CLOBETASOL PROPIONATE

    arrow
    ASC 2024
    Not Confirmed
    GLENMARK PHARMS LTD
    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLOBETASOL PROPIONATE

    Drug : CLOBETASOL PROPIONATE

    Dosage Form : AEROSOL, FOAM; TOPICAL

    Application Number : 211450

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    HALEON US HOLDINGS

    ACETAMINOPHEN; ASPIRIN; CAFFEINE

    arrow
    ASC 2024
    Not Confirmed
    HALEON US HOLDINGS
    United Kingdom
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ACETAMINOPHEN; ASPIRIN; CAFFEINE

    Drug : EXCEDRIN (MIGRAINE RELIEF)

    Dosage Form : TABLET; ORAL

    Application Number : 20802

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    HETERO LABS LTD III

    RITONAVIR

    arrow
    ASC 2024
    Not Confirmed
    HETERO LABS LTD III
    India
    arrow
    ASC 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RITONAVIR

    Drug : RITONAVIR

    Dosage Form : TABLET; ORAL

    Application Number : 204587

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    FDA Dossiers

    read-more
    read-more

    01

    Dosage Form : INJECTION, SUSPENSION, EXTENDE...

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : INJECTION, SUSPENSION, EXTENDE...

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : INTRAMUSCULAR

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 1.23

    Potency Unit : %

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Dosage Form : OINTMENT

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : OINTMENT

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : OPHTHALMIC

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 0

    Potency Unit : NA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Dosage Form : CAPSULE

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : CAPSULE

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : ORAL

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 0.08

    Potency Unit : MG

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Dosage Form : GRANULE, EFFERVESCENT

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : GRANULE, EFFERVESCENT

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : ORAL

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 0

    Potency Unit : NA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Dosage Form : SUSPENSION

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : SUSPENSION

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : ORAL

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 2.5

    Potency Unit : MG/5ML

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Dosage Form : SYRUP

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : SYRUP

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : ORAL

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 0

    Potency Unit : NA

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Dosage Form : TABLET

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : TABLET

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : ORAL

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 66.7

    Potency Unit : MG

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Dosage Form : TABLET, FILM COATED

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : TABLET, FILM COATED

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : ORAL

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 83.9

    Potency Unit : MG

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Dosage Form : AEROSOL

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : AEROSOL

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : TOPICAL

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 4.74

    Potency Unit : %W/W

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Dosage Form : EMULSION, AEROSOL FOAM

    SORBITAN MONOLAURATE
    arrow
    Formnext Forum
    Not Confirmed

    Dosage Form : EMULSION, AEROSOL FOAM

    USA
    arrow
    Formnext Forum
    Not Confirmed

    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Country
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    SORBITAN MONOLAURATE

    Route : TOPICAL

    CAS : 1338392

    UNII : 6W9PS8B71J

    Potency Amount : 4.74

    Potency Unit : %W/W

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    Only 10 entries up to this point, click to access all click full view read-more
    click full view

    EXCIPIENTS BY APPLICATIONS

    Click here to find the perfect excipient manufacturers by their capabilities

    Emulsifying Agents

    read-more
    read-more

    01

    Nanjing Well Pharmaceutical

    China
    arrow
    CPhI Worldwide, Milan
    Booth #4A116
    • fda
    • EDQM
    • WHO-GMP

    Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Dosage Form : Emulsion

    Grade : Oral, Topical

    Category : Emulsifying Agents

    Brand Name : Laurel Sorbitan (Span 20)

    Application : Emulsifying Agents

    Excipient Details : Laurel sorbitan (Span 20) is used as stabilizer, emulsifier & solubilizer in oral & topical formulations such as tablets, creams, lotions, gels, etc.

    Pharmacopoeia Ref : ChP/USP/EP

    Technical Specs : NA

    Ingredient(s) : Laurel Sorbitan

    arrow
    Laurel Sorbitan (Span 20)

    Excipients Web Link

    Market Place

    Digital Content

    Virtual Booth

    02

    Microlex e.U

    Austria
    ASC 2024
    Not Confirmed
    arrow

    03

    Seppic

    France
    ASC 2024
    Not Confirmed
    arrow

    04

    Gangwal Chemicals

    India
    ASC 2024
    Not Confirmed
    arrow

    Solubilizers

    read-more
    read-more

    Topical

    read-more
    read-more

    Surfactant Foaming Agents

    read-more
    read-more

    Thickeners And Stabilizers

    read-more
    read-more

    Film Formers Plasticizers

    read-more
    read-more
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search